Phytest

What Phytest does

Phytest is an Atlanta-based, privately held laboratory revenue cycle management (RCM) and laboratory management company founded in 1998 that exclusively serves physician-owned laboratories, hospital and health system labs, and clinical laboratories across specialties such as OB/GYN, pathology, genetics, fertility, gastroenterology, and endocrinology. The company's core offering is end-to-end lab financial management including charge capture, coding, medical-necessity verification, eligibility, prior authorizations, claim submission, payment posting, denial management, underpayment recovery, and accounts receivable management, supplemented by Molecular Laboratory Management (lab design, accreditation, staffing, and ongoing operations), Genetic Laboratory Management (lab director provision, NIPT reporting, validations, and clinical quality reporting), and add-on Laboratory Audit Services.

Underpinning the service offering is Phytest's proprietary Atlas laboratory billing software, which integrates Electronic Health Record (EHR) systems, Laboratory Information Systems (LIS), and the lab RCM platform into a single electronic workflow spanning intake, requisitioning, eligibility, testing, reporting, and billing. The platform incorporates rule engines that automate compliance with MUE (Medically Unlikely Edits), CCI (National Correct Coding Initiative) edits, medical necessity requirements, and ongoing payer policy updates, and produces real-time analytics on payer-specific CPT and diagnosis combinations. Phytest self-reports KPIs of +8-12% annual revenue uplift for client practices, a 98% clean claim rate, 100+ patient calls handled per day, and 50% faster turnaround times compared to baseline.

Phytest monetizes through a hybrid pricing model combining a recurring monthly platform fee (covering implementation, integrations, clearinghouse enrollment, and platform access with no upfront setup costs) and a percentage-based collection fee applied when Phytest collects payer or patient reimbursement on behalf of the client's in-house lab, with credit-card processing and other transactional fees passed through at cost. The go-to-market is a sales-led B2B motion targeting CFOs, lab directors, and practice administrators via consultation-based demand generation, supplemented by content marketing on topics such as genomic lab billing, pathology billing, prior authorization, and clinical laboratory legislation. Customer evidence centers on long-tenured enterprise and mid-market physician practices, including Georgia Obstetrics and Gynecology (20-year relationship) and Midwest Center for Women's Healthcare (since 2011), operating out of the corporate headquarters at 5909 Peachtree Dunwoody Rd, Suite 900, Atlanta, GA, with 11-50 employees.

Name

Phytest

Legal name

Phytest, Inc.

Website

https://phytest.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Phytest is a privately held Atlanta-based laboratory revenue cycle management and lab management company serving physician groups and health systems across OB/GYN, genetics, molecular, and pathology specialties with proprietary Atlas billing software and rules-based compliance automation.

Ownership category

akta.pro rank

Product category

Healthcare Laboratory Revenue Cycle Management

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Laboratory LIS (Core Lab/Hospital Lab) (HLACAMAA)

akta.pro secondary industries

Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery) (HLACAMAL), Lab Analytics, Utilization Management & Operational Intelligence (HLACAMAK)

Keywords

• Laboratory revenue cycle management
• Medical billing services
• Molecular lab management
• Genetic lab management
• Physician lab solutions

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Monthly Platform Fee: Phytest charges a simple monthly platform fee that covers implementation, integrations, clearinghouse enrollment, fax, mail, phone setup, and ongoing platform access. No upfront implementation or setup fees are charged.
2. Collection Fees: Percentage-based fee applied whenever Phytest collects payer or patient reimbursement on behalf of the client's in-house lab. This aligns Phytest's incentives with client revenue performance.
3. Pass-Through Fees: Credit card processing and other transactional fees are passed through at negotiated rates without markup, providing cost transparency for clients.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Phytest provides end-to-end laboratory revenue cycle management and laboratory management services for physician groups and health systems. The company manages laboratory test billing, claims submission, denial management, and revenue recovery, and also designs, builds, and operates in-house molecular and genetic laboratories. All offerings are powered by the proprietary Atlas billing software platform that integrates EHR, LIS, and RCM systems into a single workflow.

Product overview

Phytest offers an integrated suite of laboratory management and billing solutions for physician groups, hospitals, and health systems. The core portfolio consists of three main service lines: Laboratory Financial Management (comprehensive revenue cycle management and billing), Molecular Laboratory Management (lab design, buildout, and operations), and Genetic Laboratory Management (full genetic lab operations including lab director, validations, and clinical quality reporting). Additional offerings include Laboratory Audit Services for operational diagnostics, a Patient Bill Payment Portal, Client Portal for billing access, and Consultation Services. Phytest's proprietary Atlas billing software powers the RCM platform, creating interoperability between EHR, LIS, and billing systems. The company serves physician-owned laboratories, clinical laboratories, and hospital/health system labs across specialties including OB/GYN, pathology, genetics, and molecular diagnostics.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• +8-12% Annual Revenue Uplift for practices
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature3 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Xifin: Xifin is a leading cloud-based RCM and laboratory information system platform serving diagnostic labs and physician groups. It is the closest direct competitor to Phytest in lab-specific revenue cycle management and LIS-adjacent analytics.
• Aspiron (now known as Aspirion): Aspirion is a healthcare RCM firm specializing in complex claims, denials, and underpayment recovery for hospitals and specialty providers. Its denial-management and underpayment-recovery focus overlaps directly with Phytest's lab billing value proposition.
• Quadax: Quadax provides specialized revenue cycle management, billing, and denial management solutions for clinical and anatomic pathology laboratories. Like Phytest, it focuses on lab-specific billing complexity and payer-rule automation.

Broad incumbents

• Experian Health: Experian Health provides identity, eligibility, claims management, and denial-prevention solutions across providers and payers. It is a broad RCM incumbent that competes for the same physician-group and health-system RCM wallet.
• Labcorp (lab/RCM perspective): Labcorp is a major national reference laboratory with end-to-end RCM, LIS, and outreach capabilities. It is a structural alternative to insourced physician labs that Phytest helps its clients build.
• Waystar: Waystar is a large-scale healthcare revenue cycle technology platform offering claims management, denials, patient payments, and analytics to hospitals and physician groups. It competes as a broad RCM incumbent with growing lab-specific capabilities.
• CompuGroup Medical (CGM): CompuGroup Medical offers EHR, practice management, and RCM solutions to physician practices and labs globally. It is a broad incumbent with physician-office and laboratory-adjacent workflows comparable to Phytest's market.
• Availity: Availity operates a large healthcare clearinghouse and revenue cycle platform connecting providers and payers. While broader than lab billing, it overlaps with Phytest on eligibility, claim submission, and payer connectivity.
• Quest Diagnostics (lab/RCM perspective): Quest Diagnostics is one of the largest reference laboratories in the US with extensive in-house RCM capabilities. While not a direct competitor in physician-lab RCM outsourcing, it shapes the lab-services landscape Phytest serves.

Emerging players

• AKASA: AKASA applies AI and automation to healthcare revenue cycle operations for hospitals and health systems. It is an emerging player tackling RCM automation and could eventually encroach on Phytest's manual-coding and rules-engine territory.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/phytest
• Xx.com/phytest

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phytest